{
  "LWK": {
    "gene_scores": {
      "DPYD": 0.48665662334162957,
      "TPMT": 0.49432979587022835,
      "UGT1A1": 0.19230615905919873
    },
    "drug_risks": {
      "5-FU": {
        "risk_level": "Moderate",
        "score": 0.48665662334162957
      },
      "Capecitabine": {
        "risk_level": "Moderate",
        "score": 0.48665662334162957
      },
      "Thiopurines": {
        "risk_level": "Moderate",
        "score": 0.49432979587022835
      },
      "Irinotecan": {
        "risk_level": "Low",
        "score": 0.19230615905919873
      }
    },
    "recommendations": [
      "5-FU: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Capecitabine: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Thiopurines: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Irinotecan: Standard dosing appropriate. Regular monitoring recommended."
    ]
  },
  "MSL": {
    "gene_scores": {
      "DPYD": 0.4864280667277294,
      "TPMT": 0.4945546659080777,
      "UGT1A1": 0.1921266402832743
    },
    "drug_risks": {
      "5-FU": {
        "risk_level": "Moderate",
        "score": 0.4864280667277294
      },
      "Capecitabine": {
        "risk_level": "Moderate",
        "score": 0.4864280667277294
      },
      "Thiopurines": {
        "risk_level": "Moderate",
        "score": 0.4945546659080777
      },
      "Irinotecan": {
        "risk_level": "Low",
        "score": 0.1921266402832743
      }
    },
    "recommendations": [
      "5-FU: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Capecitabine: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Thiopurines: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Irinotecan: Standard dosing appropriate. Regular monitoring recommended."
    ]
  },
  "YRI": {
    "gene_scores": {
      "DPYD": 0.48971729255907154,
      "TPMT": 0.49435942836371727,
      "UGT1A1": 0.19531515220097317
    },
    "drug_risks": {
      "5-FU": {
        "risk_level": "Moderate",
        "score": 0.48971729255907154
      },
      "Capecitabine": {
        "risk_level": "Moderate",
        "score": 0.48971729255907154
      },
      "Thiopurines": {
        "risk_level": "Moderate",
        "score": 0.49435942836371727
      },
      "Irinotecan": {
        "risk_level": "Low",
        "score": 0.19531515220097317
      }
    },
    "recommendations": [
      "5-FU: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Capecitabine: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Thiopurines: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Irinotecan: Standard dosing appropriate. Regular monitoring recommended."
    ]
  },
  "GWD": {
    "gene_scores": {
      "DPYD": 0.48947330552065815,
      "TPMT": 0.49515215528084133,
      "UGT1A1": 0.19527121001390824
    },
    "drug_risks": {
      "5-FU": {
        "risk_level": "Moderate",
        "score": 0.48947330552065815
      },
      "Capecitabine": {
        "risk_level": "Moderate",
        "score": 0.48947330552065815
      },
      "Thiopurines": {
        "risk_level": "Moderate",
        "score": 0.49515215528084133
      },
      "Irinotecan": {
        "risk_level": "Low",
        "score": 0.19527121001390824
      }
    },
    "recommendations": [
      "5-FU: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Capecitabine: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Thiopurines: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Irinotecan: Standard dosing appropriate. Regular monitoring recommended."
    ]
  },
  "ESN": {
    "gene_scores": {
      "DPYD": 0.4880463912754027,
      "TPMT": 0.49582465325266434,
      "UGT1A1": 0.1938279301745636
    },
    "drug_risks": {
      "5-FU": {
        "risk_level": "Moderate",
        "score": 0.4880463912754027
      },
      "Capecitabine": {
        "risk_level": "Moderate",
        "score": 0.4880463912754027
      },
      "Thiopurines": {
        "risk_level": "Moderate",
        "score": 0.49582465325266434
      },
      "Irinotecan": {
        "risk_level": "Low",
        "score": 0.1938279301745636
      }
    },
    "recommendations": [
      "5-FU: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Capecitabine: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Thiopurines: Start with 25-50% reduced dose. Monitor closely and adjust based on response.",
      "Irinotecan: Standard dosing appropriate. Regular monitoring recommended."
    ]
  }
}